Literature DB >> 25520324

Stem and progenitor cell dysfunction in human trisomies.

Binbin Liu1, Sarah Filippi2, Anindita Roy3, Irene Roberts4.   

Abstract

Trisomy 21, the commonest constitutional aneuploidy in humans, causes profound perturbation of stem and progenitor cell growth, which is both cell context dependent and developmental stage specific and mediated by complex genetic mechanisms beyond increased Hsa21 gene dosage. While proliferation of fetal hematopoietic and testicular stem/progenitors is increased and may underlie increased susceptibility to childhood leukemia and testicular cancer, fetal stem/progenitor proliferation in other tissues is markedly impaired leading to the characteristic craniofacial, neurocognitive and cardiac features in individuals with Down syndrome. After birth, trisomy 21-mediated premature aging of stem/progenitor cells may contribute to the progressive multi-system deterioration, including development of Alzheimer's disease.
© 2014 The Authors.

Entities:  

Keywords:  Down syndrome; hematopoietic stem cells; leukemia; neural progenitors; trisomy 21

Mesh:

Year:  2014        PMID: 25520324      PMCID: PMC4304728          DOI: 10.15252/embr.201439583

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  201 in total

1.  Cellular and cis-regulation of En-2 expression in the mandibular arch.

Authors:  Karl Degenhardt; Stacey Rentschler; Glenn Fishman; David A Sassoon
Journal:  Mech Dev       Date:  2002-02       Impact factor: 1.882

Review 2.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

3.  sonic hedgehog is required in pulmonary endoderm for atrial septation.

Authors:  Andrew D Hoffmann; Michael A Peterson; Joshua M Friedland-Little; Stuart A Anderson; Ivan P Moskowitz
Journal:  Development       Date:  2009-04-15       Impact factor: 6.868

4.  Risks of leukaemia and solid tumours in individuals with Down's syndrome.

Authors:  H Hasle; I H Clemmensen; M Mikkelsen
Journal:  Lancet       Date:  2000-01-15       Impact factor: 79.321

5.  GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

Authors:  Johann K Hitzler; Joseph Cheung; Yue Li; Stephen W Scherer; Alvin Zipursky
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

6.  Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.

Authors:  Lisa E Olson; Randall J Roper; Crystal L Sengstaken; Elizabeth A Peterson; Veronica Aquino; Zygmunt Galdzicki; Richard Siarey; Mikhail Pletnikov; Timothy H Moran; Roger H Reeves
Journal:  Hum Mol Genet       Date:  2007-03-05       Impact factor: 6.150

7.  Deficits in human trisomy 21 iPSCs and neurons.

Authors:  Jason P Weick; Dustie L Held; George F Bonadurer; Matthew E Doers; Yan Liu; Chelsie Maguire; Aaron Clark; Joshua A Knackert; Katharine Molinarolo; Michael Musser; Lin Yao; Yingnan Yin; Jianfeng Lu; Xiaoqing Zhang; Su-Chun Zhang; Anita Bhattacharyya
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

8.  Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.

Authors:  Oliver Tunstall-Pedoe; Anindita Roy; Anastasios Karadimitris; Josu de la Fuente; Nicholas M Fisk; Phillip Bennett; Alice Norton; Paresh Vyas; Irene Roberts
Journal:  Blood       Date:  2008-08-08       Impact factor: 22.113

9.  MPLW515L mutation in acute megakaryoblastic leukaemia.

Authors:  K Hussein; O Bock; K Theophile; K Schulz-Bischof; A Porwit; J Schlue; D Jonigk; H Kreipe
Journal:  Leukemia       Date:  2009-02-05       Impact factor: 11.528

10.  Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.

Authors:  Youssef Hibaoui; Iwona Grad; Audrey Letourneau; M Reza Sailani; Sophie Dahoun; Federico A Santoni; Stefania Gimelli; Michel Guipponi; Marie Francoise Pelte; Frédérique Béna; Stylianos E Antonarakis; Anis Feki
Journal:  EMBO Mol Med       Date:  2013-12-27       Impact factor: 12.137

View more
  14 in total

1.  Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.

Authors:  Blandine Ponroy Bally; W Todd Farmer; Emma V Jones; Selin Jessa; J Benjamin Kacerovsky; Alexandre Mayran; Huashan Peng; Julie L Lefebvre; Jacques Drouin; Arnold Hayer; Carl Ernst; Keith K Murai
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

2.  Transcriptome Profiling Uncovers Potential Common Mechanisms in Fetal Trisomies 18 and 21.

Authors:  Marija Volk; Aleš Maver; Alenka Hodžić; Luca Lovrečić; Borut Peterlin
Journal:  OMICS       Date:  2017-10

3.  Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome.

Authors:  Bradley Pawlikowski; Nicole Dalla Betta; Tiffany Elston; Darian A Williams; Bradley B Olwin
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

Review 4.  Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?

Authors:  Laura Reiche; Patrick Küry; Peter Göttle
Journal:  Cells       Date:  2019-12-07       Impact factor: 6.600

Review 5.  Down syndrome, accelerated aging and immunosenescence.

Authors:  Noémie Gensous; Maria Giulia Bacalini; Claudio Franceschi; Paolo Garagnani
Journal:  Semin Immunopathol       Date:  2020-07-23       Impact factor: 9.623

6.  The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis.

Authors:  Shaobo Li; Thomas Jackson; Natalina Elliot; Ivo S Muskens; Helen M Hansen; Swe Swe Myint; Priyatama Pandey; Jeremy M Schraw; Ritu Roy; Joaquin Anguiano; Katerina Goudevenou; Kimberly D Siegmund; Philip J Lupo; Marella F T R de Bruijn; Kyle M Walsh; Paresh Vyas; Xiaomei Ma; Anindita Roy; Irene Roberts; Joseph L Wiemels; Adam J de Smith
Journal:  Nat Commun       Date:  2021-02-05       Impact factor: 14.919

7.  Integrative Analysis Extracts a Core ceRNA Network of the Fetal Hippocampus With Down Syndrome.

Authors:  Shengran Wang; Xia Tang; Litao Qin; Weili Shi; Shasha Bian; Zhaokun Wang; Qingqing Wang; Xin Wang; Jianqin Gu; Bingtao Hao; Keyue Ding; Shixiu Liao
Journal:  Front Genet       Date:  2020-11-30       Impact factor: 4.599

8.  Correction of Down syndrome and Edwards syndrome aneuploidies in human cell cultures.

Authors:  Tomokazu Amano; Emiko Jeffries; Misa Amano; Akihiro C Ko; Hong Yu; Minoru S H Ko
Journal:  DNA Res       Date:  2015-08-31       Impact factor: 4.458

Review 9.  Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.

Authors:  Neha Bhatnagar; Laure Nizery; Oliver Tunstall; Paresh Vyas; Irene Roberts
Journal:  Curr Hematol Malig Rep       Date:  2016-10       Impact factor: 3.952

10.  Down syndrome iPSC model: endothelial perspective on tumor development.

Authors:  Mariana Perepitchka; Yekaterina Galat; Igor P Beletsky; Philip M Iannaccone; Vasiliy Galat
Journal:  Oncotarget       Date:  2020-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.